A Position Paper of the North American Society for Pediatric Gastroenterology and Nutrition

Richard B. Colletti(Greenville College), Peter R. Durie(University of Toronto), Ronald J. Sokol(Children's Hospital Colorado), Harland S. Winter(Philadelphia University), Frederick J. Suchy(Mount Sinai Medical Center), William J. Klish(Boston University)
Journal of Pediatric Gastroenterology and Nutrition
January 1, 1998
10.1097/00005176-199801000-00018
Cited by 14

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children
|Journal of Pediatric Gastroenterology and Nutrition|2001|628
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|496
Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices
|Journal of Pediatric Gastroenterology and Nutrition|2012|493
International Liver Transplant Society Practice Guidelines
|Transplantation|2016|440